Form 4: Cytokinetics Director Acquires Shares Through Stock Retainer Plan

Director Robert Arthur Harrington acquired 324 shares of Cytokinetics Inc. common stock at $38.56 per share through the Director Stock in lieu of Cash Retainer Plan.

Summary

• On April 15, 2025, Robert Arthur Harrington, a director of Cytokinetics Inc., acquired 324 shares of common stock.
• The shares were acquired through the Director Stock in lieu of Cash Retainer Plan.
• The price per share was $38.56.
• Following the transaction, Harrington beneficially owns 14,982 shares of Cytokinetics Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares signals confidence, but it's a routine transaction.

Positives

• The director's participation in the stock retainer plan demonstrates confidence in the company's future.

Industry Context

Directors acquiring company stock is generally viewed positively, as it aligns their interests with those of shareholders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Cytokinetics, Director, Stock Acquisition, Form 4, Beneficial Ownership, CYTK, Stock Retainer Plan